Skip to main content

Table 1 Participants characteristics at enrollment and follow-up, Mali 2015–2016

From: Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 20152016

Study arm

AL (225)

ASAQ (224)

p-value

Participant characteristics at baseline

 Median age, month (range)

36.0 (7–59)

36.0 (6–59)

0.970

 Median weight, kg (range)

13.0 (9–21)

13.3 (9–20)

0.872

 Number male/female

126/99

111/113

0.083

 Median pre-treatment parasitemia, parasites/µL (range)

11,750 (2000–199,800)

11,825 (2000–197,500)

0.659

 Median pre-treatment hemoglobin (g/dL)

9.4 (5–13)

9.0 (5–13)

0.161

  1. AL: artemether–lumefantrine; ASAQ: artesunate–amodiaquine